Ascend Capital’s Otonomy, Inc. OTIC Stock Holding History

Ascend Capital’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-118,600	Closed	-$2.11M	–	179
2015 Q3	$2.11M	Buy	+118,600	New	+$2.81M	0.08%	111

Other funds holding OTIC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ascend Capital's OTIC Position: Q4 2015 in Review

Ascend Capital sold out of Otonomy, Inc. (OTIC) in Q4 2015, closing a stake of 118,600 shares — an estimated $2.11M sold.

Ascend Capital first reported a position in OTIC in Q3 2015 and held it in 1 quarter. The position peaked at $2.11M in Q3 2015. 85 funds tracked by Wall St. Rank hold OTIC as of Q4 2015.

Ascend Capital reported no remaining Otonomy, Inc. position as of Q4 2015 after selling out during the quarter.
Ascend Capital sold 118,600 Otonomy, Inc. shares in Q4 2015, an estimated $2.11M.
Ascend Capital first reported a position in Otonomy, Inc. in Q3 2015 and held it in 1 quarter.
Ascend Capital's Otonomy, Inc. position peaked at $2.11M in Q3 2015.
85 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q4 2015.

Based on Ascend Capital's 13F filing for Q4 2015, filed 12 Feb 2016.